-
PublishedJune 6, 2023
Merck sues U.S., calling Biden move to cut drug prices ‘extortion’
Merck argues the negotiation process outlined in President Biden's Inflation Reduction Act violates the Constitution.
-
PublishedApril 9, 2023
Mainers navigate shortage of critical ADHD medication
Widely known by its brand names, including Adderall, the drug has been a life-changer for people with attention-deficit/hyperactivity disorder.
-
PublishedMarch 15, 2023
Biden says he’s focused ‘intensely’ on lowering drug costs
The president – gearing up for an expected reelection announcement – aims to make the effort central to his policy and political agenda.
-
PublishedAugust 9, 2022
Insulin price cap championed by Collins stripped from spending bill by fellow Republicans
Sens. Susan Collins and Angus King both have sought to cap the drug's price, which has shot up tenfold in the U.S. – but not other countries - in 20 years.
-
PublishedJune 29, 2022
Federal task force to crack down on overprescription of opioids in the region
Four additional federal prosecutors will help local and federal law enforcement bring criminal cases against doctors and medical providers who are diverting opiates for profit.
-
PublishedApril 1, 2022
U.S. House passes $35-a-month insulin cap as Democrats seek wider bill
For the legislation to pass Congress, 10 Republican senators would have to vote in favor.
-
PublishedFebruary 14, 2022
Bill aims to lower the cost of the most expensive prescription drugs for Mainers
The bill would ensure that Mainers pay no more for prescription medications than their Canadian neighbors.
-
PublishedNovember 9, 2021
Oklahoma court overturns $465 million opioid ruling against Johnson & Johnson
The Oklahoma Supreme Court weighed whether the company’s marketing and sale of opioids created a public nuisance.
-
PublishedNovember 2, 2021
Democrats reach deal on lowering drug prices; Biden upbeat on Manchin
Democrats are looking to cap out-of-pocket Medicare drug costs at $2,000 and reduce the price of insulin, as part of President Biden's $1.75 trillion domestic policy proposal.
-
PublishedMay 27, 2021
Legislative panel votes down bill to penalize drug companies for price gouging
The pharmaceutical industry has made it clear that it will sue Maine if the state approves the ‘excessive pricing’ bill, which now goes to the full Legislature.
- 1
- 2
- 3
- Next Page →
